About
Basic Data Updated:
2 months agoThe Corporate was formerly known as Cadila Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 120.65 cr and a paid-up capital of Rs 80.01 cr.
The Corporate currently has active open charges totaling ₹3,516.55 cr. It has already closed loans amounting to ₹1,751.66 cr, as per the Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Cadila Pharmaceuticals Limited India are Kamlesh Shah as Cfo and Nirajkumar Jain as Company Secretary. Girdhar Balwani, Rajiv Modi, Ramesh Choksi, and Three other members serve as directors at the Company.
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
CIN/LLPIN/FCRN | U24231GJ1991PLC015132 |
Company No. | 015132 |
Company Classification | Public Limited Indian Non-Government Company |
Incorporation Date | 28 Feb 1991 |
Date of AGM | 25 Aug 2023 |
Date of Balance Sheet | 31 Mar 2023 |
Listing Status | Unlisted |
ROC Code | Roc Ahmedabad |
Products or Services related to Cadila Pharmaceuticals Limited
Financials of Cadila Pharmaceuticals Limited
Cadila Pharmaceuticals Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 0.44% decrease. The company also saw a substantial fall in profitability, with a 93.85% decrease in profit. The company's net worth Soared by an impressive increase of 54.21%.
Corporate Structure
Unlock access to Cadila Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Cadila Pharmaceuticals Limited
Unlock and access historical data on people associated with Cadila Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (3)
RM
Rajiv Modi Managing DirectorAppointment Date: 28-Feb-1991
Status: Current
KS
Kamlesh Shah CFOAppointment Date: 22-Dec-2022
Status: Current
NJ
Nirajkumar Jain Company SecretaryAppointment Date: 27-Sep-2023
Status: Current
Board Members(5)
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Canara Bank Creation Date: 29 Sep 2023 | ₹300.00 Cr | Open |
Hdfc Bank Limited Creation Date: 27 Jun 2023 | ₹138.75 Cr | Open |
Bank Of India Creation Date: 23 Jun 2023 | ₹100.00 Cr | Open |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cadila Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cadila Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
Irm Enterprises Private Limited
Active 14 years 11 monthsRajiv Modi, Ramesh Choksi and 1 more are mutual person
Redefine Leisure Private Limited
Active 16 years 7 monthsRajiv Modi and Ramesh Choksi are mutual person
Recent activity within the organization
Director Appointment
Parul Nikunj Shah was appointed as a Director was appointed as a Director on 16 Apr 2024 & has been associated with this company since 4 months 23 days .
16 Apr 2024Director Appointment
Manvantkumar Shankerlal Rami was appointed as a Director was appointed as a Director on 16 Apr 2024 & has been associated with this company since 4 months 23 days .
16 Apr 2024Charges
A charge with Canara Bank amounted to Rs. 300.00 cr with Charge ID 100800466 was registered on 29 Sep 2023.
29 Sep 2023Charges
A charge with Others of Rs. 1,143.52 cr registered on 21 Jun 2002 with Charge ID 90103281 was modified on 26 Sep 2023.
26 Sep 2023Charges
A charge registered on 25 Mar 2014 via Charge ID 10490013 with Export-Import Bank Of India was fully satisfied on 25 Sep 2023.
25 Sep 2023
Recent News, Updates & Announcement
- Cadila Pharma receives Healthcare leadership award.
BioSpectrum India 27 Nov 2017
- Cadila Healthcare Q2 profit up 32 at Rs 503 crore.
4-Traders 15 Nov 2017
- Cadila settles patent litigation related to Livalo tablets.
Livalo tablets are indicated as an adjunctive therapy to diet to reduce elevated total cholesterol .
Deccan Chronicle 17 Jan 2017
- Bhoruka Logistics in talks with PE strategic investors to raise Rs100 crore Mint.
Strategic investors are interested in picking up at least 51 stake in Bhoruka Logistics which would also include picking up some stake from promoters.
mint 31 Aug 2016
Frequently asked questions
What is the Incorporation or founding date of Cadila Pharmaceuticals Limited?